跳至主要内容
临床试验/JPRN-UMIN000024942
JPRN-UMIN000024942已完成未知

Venous Thromboembolism (VTE) in Cancer Patients;a Multicenter Prospective Registry - Cancer-VTE Registry

Medical Science Department Daiichi Sankyo Company, Limited.0 个研究点目标入组 10,202 人开始时间: 2017年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10,202

研究概览

简要总结

The cumulative incidences of symptomatic VTE, bleeding, and all-cause death one year after enrollment were 0.5%, 1.4%, and 12.2%, respectively. Symptomatic VTE was more common in patients with pancreatic cancer and patients with Stage IV disease regardless of cancer type. Patients with VTE before initiation of cancer treatment, even asymptomatic distal DVT, had a higher risk of subsequent symptomatic VTE, bleeding, and all-cause death.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • A patient who is inappropriate as a subject of the study judged by investigator.

研究者

发起方
Medical Science Department Daiichi Sankyo Company, Limited.

相似试验

Venous Thromboembolism (VTE) in Cancer Patients;a... | 临床试验